Revvity, Inc. , today announced the launch of EUROIMMUN's CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against ...
The firm's Anti-Measles Virus ELISA 2.0 (IgG) is used with dried blood spot samples to identify infections and determine patients' immune status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback